This inventor holds 1 USPTO granted patent. Top assignee: Lipideon Biotechnology Ag. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovations by Tobias Ritter in Hypocholesterolemic Compounds
Introduction
Tobias Ritter is an accomplished inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at reducing cholesterol levels.
Latest Patents
Ritter holds a patent for novel hypocholesterolemic compounds, which are described in his invention as useful in the treatment and prevention of atherosclerosis. The compounds are formulated to effectively reduce cholesterol levels and are included in pharmaceutical compositions that may combine these compounds with other active agents.
Career Highlights
Tobias Ritter is associated with Lipideon Biotechnology AG, a company focused on innovative solutions in biotechnology. His work has been pivotal in advancing treatments that address cholesterol-related health issues.
Collaborations
Ritter collaborates with notable professionals in his field, including Helmut Hauser and Lisbet Kvaerno. Their combined expertise contributes to the ongoing research and development efforts at Lipideon Biotechnology AG.
Conclusion
Tobias Ritter's innovative work in hypocholesterolemic compounds showcases his commitment to improving health outcomes through scientific advancements. His contributions are vital in the ongoing battle against cholesterol-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile